Together, these results identified SIRPα+ myeloid cells -in particular cDC2s, monocytes and TAMs- as a potentially relevant target population in human GBM, and verify that mouse GBM functions as a good model system in this context. This evidence concerns the gene SIRPA and glioblastoma.